Oral medicines represent the largest pharmaceutical market
area.
To achieve a therapeutic effect, a drug must penetrate the intestinal
walls, the main absorption site for orally delivered active pharmaceutical
ingredients (APIs). Indeed, predicting drug absorption can facilitate
candidate screening and reduce time to market. Algorithms are available
with good prediction accuracy that however focus only on solubility.
In this work, we focused on drug permeability looking at human intestinal
absorption as a marker for intestinal bioavailability. Being of considerable
therapeutic relevance, APIs with serotonergic activity were selected
as a dataset. Due to process complexity, experimental data scarcity,
and variability, we turned toward an artificial intelligence (AI)-based
system, which is a hierarchical combination of classification and
regression models. This combination of seemingly two models into a
single system widens the space of molecules classified as highly permeable
with high accuracy. The specialized and optimized system enables in
silico and structure-based prediction with a high degree of certainty.
Predictions in external validation allowed correct selection of the
38% of highly permeable molecules without any false positives. The
proposed system based on AI represents a promising tool useful for
oral drug screening at an early stage of drug discovery and development.
Datasets and the obtained models are available on the GitHub platform
().